NMRD - Nemaura Medical Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5122.77M
Enterprise Value 3121.6M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-24.33

Trading Information

Stock Price History

Beta (5Y Monthly) -0.44
52-Week Change 3-45.88%
S&P500 52-Week Change 3-11.36%
52 Week High 314.80
52 Week Low 32.50
50-Day Moving Average 35.49
200-Day Moving Average 35.62

Share Statistics

Avg Vol (3 month) 334.6k
Avg Vol (10 day) 313.62k
Shares Outstanding 520.81M
Float 6.66M
% Held by Insiders 168.01%
% Held by Institutions 10.00%
Shares Short (Mar. 12, 2020) 432.03k
Short Ratio (Mar. 12, 2020) 40.37
Short % of Float (Mar. 12, 2020) 40.48%
Short % of Shares Outstanding (Mar. 12, 2020) 40.15%
Shares Short (prior month Feb. 13, 2020) 48.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec. 04, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar. 30, 2019
Most Recent Quarter (mrq)Dec. 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-79.88%
Return on Equity (ttm)-303.76%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -5M
Net Income Avi to Common (ttm)-4.44M
Diluted EPS (ttm)-0.21
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.07M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)104.14k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.52
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-3.81M
Levered Free Cash Flow (ttm)-3.38M